TABLE 6.
Antifungal sensitivity and resistance among adult and pediatric patients.
| Drug | Culture sensitivity | Age group | p | |
|---|---|---|---|---|
| Adult | Pediatric | |||
| Amphotericin B | Sensitive | 1178 (98.7%) | 235 (98.7%) | 0.85 |
| Resistant | 13 (1.1%) | 3 (1.3%) | ||
| Intermediate sensitivity | 3 (0.2%) | 0 (0.0%) | ||
| Caspofungin | Sensitive | 1168 (97.8%) | 236 (99.2%) | 0.51 |
| Resistant | 13 (1.1%) | 1 (0.4%) | ||
| Intermediate sensitivity | 13 (1.1%) | 1 (0.4%) | ||
| Micafungin | Sensitive | 1183 (99.1%) | 238 (100%) | 0.22 |
| Resistant | 11 (0.9%) | 0 (0.0%) | ||
| Fluconazole | Sensitive | 1151 (96.4%) | 224 (94.1%) | 0.10 |
| Resistant | 43 (3.6%) | 14 (5.9%) | ||
| Voriconazole | Sensitive | 1178 (98.7%) | 234 (98.3%) | 0.76 |
| Resistant | 16 (1.3%) | 4 (1.7%) | ||
| Flucytosine | Sensitive | 1179 (98.7%) | 238 (100%) | 0.15 |
| Resistant | 15 (1.3%) | 0 (0.0%) | ||